1. Academic Validation
  2. Reversible bone marrow reticulin fibrosis as a side effect of romiplostim therapy for the treatment of chronic refractory immune thrombocytopenia

Reversible bone marrow reticulin fibrosis as a side effect of romiplostim therapy for the treatment of chronic refractory immune thrombocytopenia

  • Pathology. 2011 Aug;43(5):520-2. doi: 10.1097/PAT.0b013e328348fecc.
Teresa Leung Julie Lokan Paul Turner Carole Smith
Figures
Products